A1c Testing Team G, Chart Review SAMUEL LAI 1/2015.

Slides:



Advertisements
Similar presentations
Web-based Application for Transfer-Discharge Medication Reconciliation Nick Honcharik, Pharm. D. Regional Pharmacy Manager WRHA.
Advertisements

University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
Cost analysis project : Ordering Magnesium and Phosphorus Pouneh Nasseri R2 12/17/12.
Overview: 1)Risk Adjustment. Program establish by Centers for Medicare and Medicaid Services [CMS] GOAL: to allocate resources to those patients who most.
Chart Review Duplicate testing of Hemoglobin A1c in patients admitted to UCI under medicine team D Samantha Harris UCI Internal Medicine Residency October.
MMI Task Force on Diabetes House Staff Curriculum.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
+ A Vitamin T Overdose? : An audit of piperacillin/ tazobactam use at Royal Perth Hospital Amelia Davis and Matthew Hanson Contributors: Dr Susan Benson,
B USINESS IN M EDICINE H OW ARE WE USING T ELEMETRY ? Asad Qasim MD, MPH – PGY2.
GXT 2008-CH 2 HEALTH SCREENING AND RISK STRATIFICATION Occurs prior to testing or exercise participation Allows for risk stratification to ensure safety.
The Prevalence of Male Hypotestosteronism in Type 2 Diabetics in a Southwest Virginia Population Dr. Eric Hofmeister Dr. Christopher Bishop.
A medical test to determine the ability of an individual to maintain HOMEOSTASIS of Blood Glucose The most commonly performed version of the Test (OGTT)
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
DVT/VTE Nursing Protocol (Deep Vein Thrombosis) (Venous Thromboembolism) Presented by Maribeth Desiongco MA, RN-BC 2008.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Investigator Meeting for New NETT Hubs November 12, 2012 NIH-NINDS U01 NSO69498.
Unity Point Palliative Care Services
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.
Duplicate HgA1c Testing
EKGs in pre-operative management for OSH transfers.
GI prophylaxis - Should I order it or not -
Objectives  Identify appropriate usage of BMP  Evaluate UCI Medicine Ward teams on usage of daily BMP and determining how often residents over-order.
Inpatient Glycemic Management
TRICOUNTY TECHNICAL COLLEGE NURSING 101 CLINICAL PREPARATION Pathophysiology (disease process and/or medical diagnosis) Medical Diagnoses: 1. Hypertension.
Expected Mortality CHF, COPD & Afib –WOB, Sats, RR –BiPAP –ABG results –Thin, sunken temples –BP, gtt’s started Expected Mortality Rate: 1.7% CHF, COPD.
Patient Centered Medical Home at a CHD Okaloosa County Health Department Opportunity Health Clinic.
Pre-operative Identification of the “At Risk” Elderly Surgical Patient Penticton Regional Hospital Presenters: Jennifer Lindsay Sarah Paul.
Corticosteroid dosing in the treatment of acute exacerbations of COPD Kurt A. Wargo, Pharm.D., BCPS, Takova D. Wallace, Pharm.D. Candidate 2014, Ryan E.
PREVELANCE OF COMPLICATIONS OF DIABETES MELLITUS IN EGYPT Prof Morsi Arab University of Alexandria.
Medicare Documentation & ICD-9-CM Coding Presented by Rhonda Anderson, RHIA President Anderson Health Information Systems, Inc
Hosted by The STEP collaborative Rules You must answer in the form of a question – (we might be a little generous here) You have 5 seconds to answer.
Diagnosis Glucose tolerance is classified into three broad categories: normal glucose homeostasis, diabetes mellitus, and impaired glucose homeostasis.
1 Module 5 Pharmacologic Management of Hospital Hyperglycemia: Insulin Management Part 2 Diabetes Special Interest Group Georgia Hospital Association.
Monitoring Physical Health Stephen R. Marder, M.D. Professor, Semel Institute for Neuroscience and Human Behavior at UCLA Director, VA VISN 22 Mental Illness.
Who?16 Million Americans (6% of pop’n) (only about 2/3 are diagnosed) 7% of Americans have Impaired Fasting Glucose (IFG; >110-
Community Acquired Pneumonia (CAP)
Unnecessary Lipid Screening of Inpatient Admissions Dennis Whang 4/2/12 DSR2.
Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,
Special Situations In The Management Of In-Patient Hyperglycemia
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
Bariatric Surgery for T2DM The STAMPEDE Trial. A.R. BMI 36.5 T2DM diagnosed age 24 On Metformin, glyburide  insulin Parents with T2DM, father on dialysis.
Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.
A two stage screening process – the pre-diabetes pathway.
Post-implementation study on appropriate GI prophylaxis in the Inpatient Setting David Nguyen 5/14/12.
Ordering CT Heads on the inpatient setting An Update of the Original Project from January 2012 Cost Containment Project DSR II June 2016 Thi Mai, PGY-2.
Jennifer Mah, MD March  Community acquired pneumonia is often suspected from clinical symptoms and physical exam  Diagnosis is confirmed on CXR.
Inpatient Glycemic Management
Physical Health and People with a Severe Mental Illness
What the Diff? (Cost Analysis Project)
What every Family Physician needs to know about Medicare Risk Adjustment? Valerie Green-Amos, M.D., FAAFP President, J. Mario Molina M.D., P.C.
Co-amoxiclav prescribing: York House Medical Practice
Venous Thromboembolism Prophylaxis for Medical Inpatients
Business in Medicine Project Presentation
Inpatient Laboratory Testing: To A1c or Not to A1c
Evaluation of Patients with chest pain Admitted under General Medicine; Has clinical judgment being taken over by serial troponins? Dr. Samantha Herath.
Diabetes Collaborative UMC NHC
Not Wanting to Miss a Beat – Is it Costing Us?
WHAT IS THE REAL NORMAL RANGE?
Examples for Nutrition Care Process
Meningitis Surveillance and investigation of causes of altered mental status among Kamuzu Central Hospital admissions, Lilongwe, Malawi Charles Kyriakos.
BMP Ordering Practice Among UCI Wards Teams
TIA/Stroke (1) C.L.I.P.S. Why do we care?
COPD Exacerbation (1) C.L.I.P.S.
Ordering Sputum Cultures in Community Acquired Pneumonia
Inpatient Insulin Management on the Wards
Diabetes screening and diagnosis
MANDATORY INSULIN EDUCATION
Presentation transcript:

A1c Testing Team G, Chart Review SAMUEL LAI 1/2015

Goals + Methods  GOALS  Promote cost-consciousness in our inpatient ward teams  Specifically, reducing unnecessary repeat lab testing  Methods  Chart review of the 15 patients admitted to Team G  Reviewing if and when A1c was ordered  Evaluating appropriate use of A1c testing given current guidelines

Guidelines  When is A1c testing warranted?  No inpatient guidelines, but the following are outpatient guidelines  Fasting glucose > 100 mg/dL, Random Glucose > 200 mg/dL with symptoms  Comorbidities of HTN, HLD  Diabetic with no A1c within 3 months (including those with no previous records)  When is it not warranted?  No history of DM II, HTN, HLD  A1c charted within the last 3 months

Initial Evaluation  Out of 15 patients  6 patients with A1c checked  5 patients during this admission  1 patient within the last 3 months  Appropriate?  Of the 6 patients, all 6 were appropriate usages of A1c  2 pts admitted for diabetes related illnesses (DKA)  All 6 had risk factors for diabetes, including HTN, HLD or BMI > 25

The Table Patient’s HistoryA1c HistoryAppropriate? 33 y/o DM I, ESRD, CRPS admitted for DKA Last A1c was 10.7 on 10/28 A1c checked, 12.1 on 1/22 Yes, last A1c was > 3 months ago in a diabetic patient 54 y/o IDDM, HFrEF, Obesity, HLD admitted for R ankle fracture Last A1c = none in chart (Transfer) A1c checked, 9.6 on 1/1 Yes, no known A1c in patient with IDDM 58 y/o schizophrenia, IDDM, admitted for auditory hallucinations Last A1c = none in chart (Transfer) A1c checked, 8.9 on 1/21 Yes, no known A1c in patient with IDDM 44 y/o DM II, HIV admitted for pneumonia Last A1c = 5.8 on 9/2014 A1c checked, 6.6 on 1/22 Yes, DM II patient with last A1c > 3 months ago 32 y/o DM II admitted for DKALast A1c = none in chart A1c checked, 6.8 on 1/16 Yes, DKA patient with no A1c listed in our charts 69 y/o HTN, Afib, Hx of ICH, admitted for sepsis from UTI Last A1c = 4.9 on 12/31 No A1c checked on this admission Yes, no repeat A1c as last one was 3 months ago, normal

Discussion  Should we test more?  Other patients were:  35 y/o = DM II, 3 DM meds, no A1c in our files  55 y/o = morbidly obese, FSG in > 150s, cirrhotic patient  43 y/o = IDDM, osteomyelitis 2/2 ulcer, no A1c in our files  84 y/o = DM II, fractured hip, daily glucose in 200s, no A1c in our files  32 y/o = morbidly obese, HTN, no A1c in our files  All of these patients meet criteria for A1c testing

Previous Study  Done by Samantha Harris in 2012  Showed similar findings as above for 15 patients on Team D

PatientPertinent History A1c / date performed Appropriate vs. Inappropriate 1) History of diabetes, presented with cellulitis 8.3% 1/23/12 Appropriate Did not recheck during hospitalization 2) No history of diabetes, presented with SOB from COPD 6.0% 2/1/12 ? Ordered by Gottschalk PCP Did not recheck during hospitalization 3) Admitted for DKA, and sepsis from pyelonephritis 14.7% 2/14/12 Appropriate No prior A1c on file, no prior admission. 4) Admitted for PNA, AMS and meningitis, with impaired fasting glucose levels % 2/12/12 Appropriate 5) History of diabetes, admitted with AMS from metastatic cancer 7.6% 2/12/12 Appropriate No prior A1c on file, Starting steroids. 6) History of diabetes, hyperglycemia, admitted for AMS 9.4% 2/15/12 Appropriate No prior A1c of file.

Problems/Concerns  Do we not check enough?  As noted in previous slide, multiple reasons to check  However, would it have changed management?  Did patients have transfer labs with A1c on them?  Did we forego checking as patient had out of system PCP?  Small sample size  Patients on steroids, active infection, may not need A1c